Cargando…

Lipid metabolic reprogramming in cancer cells

Many human diseases, including metabolic, immune and central nervous system disorders, as well as cancer, are the consequence of an alteration in lipid metabolic enzymes and their pathways. This illustrates the fundamental role played by lipids in maintaining membrane homeostasis and normal function...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beloribi-Djefaflia, S, Vasseur, S, Guillaumond, F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728678/ https://www.ncbi.nlm.nih.gov/pubmed/26807644 http://dx.doi.org/10.1038/oncsis.2015.49

Ejemplares similares

Exosomal lipids impact on tumoral cell behavior
por: Lombardo, Dominique, et al.
Publicado: (2015)

Influence of the Tumor Microenvironment on Cancer Cells Metabolic Reprogramming
por: Gouirand, Victoire, et al.
Publicado: (2018)

Exosomal lipids induce human pancreatic tumoral MiaPaCa-2 cells resistance through the CXCR4-SDF-1α signaling axis
por: Beloribi-Djefaflia, Sadia, et al.
Publicado: (2014)

Lipids in cancer: a global view of the contribution of lipid pathways to metastatic formation and treatment resistance
por: Vasseur, Sophie, et al.
Publicado: (2022)

The metabolic facet of pancreatic cancer: How hypoxia shapes fatal cancer cells
por: Guillaumond, Fabienne, et al.
Publicado: (2013)

Reprogrammed Lipid Metabolism and the Lipid-Associated Hallmarks of Colorectal Cancer
por: Salita, Timothy, et al.
Publicado: (2022)

Lipid metabolism reprogramming and its potential targets in cancer
por: Cheng, Chunming, et al.
Publicado: (2018)

Lipid Metabolic Reprogramming in Hepatocellular Carcinoma
por: Nakagawa, Hayato, et al.
Publicado: (2018)

Lipid Metabolism Reprogramming of Immune Cells in Acne: An Update
por: Wu, Shuhui, et al.
Publicado: (2023)

Targeting Lipid Metabolic Reprogramming as Anticancer Therapeutics
por: Cha, Ji-Young, et al.
Publicado: (2016)

The role of lipid metabolic reprogramming in tumor microenvironment
por: Yang, Kai, et al.
Publicado: (2023)

Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification
por: Talapatra, Jyotirmayee, et al.
Publicado: (2023)

Lipid metabolism reprogramming in head and neck cancer
por: Liang, Jinfeng, et al.
Publicado: (2023)

Novel strategy for oncogenic alteration-induced lipid metabolism reprogramming in pancreatic cancer: The function of lipid metabolism reprogramming in pancreatic cancer
por: Guo, Duancheng, et al.
Publicado: (2023)

Lipid metabolic reprogramming as an emerging mechanism of resistance to kinase inhibitors in breast cancer
por: Feng, William W., et al.
Publicado: (2020)

Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming
por: Li, Zhenzhen, et al.
Publicado: (2021)

Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives
por: Pellerin, Laurence, et al.
Publicado: (2020)

Lipid metabolism reprogramming in tumor-associated macrophages and implications for therapy
por: Qiao, Xuehan, et al.
Publicado: (2023)

Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics
por: Jin, Hao-Ran, et al.
Publicado: (2023)

Dysregulated metabolic enzymes and metabolic reprogramming in cancer cells
por: Sreedhar, Annapoorna, et al.
Publicado: (2018)

Reprogrammed lipid metabolism in bladder cancer with cisplatin resistance
por: Lee, Min Young, et al.
Publicado: (2018)

Reprogramming of Lipid Metabolism in Lung Cancer: An Overview with Focus on EGFR-Mutated Non-Small Cell Lung Cancer
por: Eltayeb, Kamal, et al.
Publicado: (2022)

Lipid metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy
por: Liu, Hui, et al.
Publicado: (2023)

Orchestral role of lipid metabolic reprogramming in T-cell malignancy
por: Mehta, Arundhati, et al.
Publicado: (2023)

Clinical significance of T cell metabolic reprogramming in cancer
por: Herbel, Christoph, et al.
Publicado: (2016)

Immune cell metabolism and metabolic reprogramming
por: Hu, Chenchen, et al.
Publicado: (2022)

Aberrant lipid metabolism reprogramming and immune microenvironment for gastric cancer: a literature review
por: Cui, Meng-Ying, et al.
Publicado: (2021)

Cholesterol reprograms glucose and lipid metabolism to promote proliferation in colon cancer cells
por: Mayengbam, Shyamananda Singh, et al.
Publicado: (2023)

Reprogramming of lipid metabolism in cancer-associated fibroblasts potentiates migration of colorectal cancer cells
por: Gong, Jin, et al.
Publicado: (2020)

Metabolic reprogramming in prostate cancer
por: Ahmad, Fahim, et al.
Publicado: (2021)

The role of noncoding RNAs in metabolic reprogramming of cancer cells
por: Safi, Amir, et al.
Publicado: (2023)

Targeting Strategies for Aberrant Lipid Metabolism Reprogramming and the Immune Microenvironment in Esophageal Cancer: A Review
por: Cui, Meng-Ying, et al.
Publicado: (2022)

The cancer metabolic reprogramming and immune response
por: Xia, Longzheng, et al.
Publicado: (2021)

Evolutionary Origins of Metabolic Reprogramming in Cancer
por: García-Sancha, Natalia, et al.
Publicado: (2022)

The Role of Reprogrammed Glucose Metabolism in Cancer
por: Ediriweera, Meran Keshawa, et al.
Publicado: (2023)

Metabolic reprogramming in cancer: Mechanisms and therapeutics
por: Nong, Shiqi, et al.
Publicado: (2023)

New Insights on the Role of Lipid Metabolism in the Metabolic Reprogramming of Macrophages
por: Batista-Gonzalez, Ana, et al.
Publicado: (2020)

Correction: Cholesterol reprograms glucose and lipid metabolism to promote proliferation in colon cancer cells
por: Mayengbam, Shyamananda Singh, et al.
Publicado: (2023)

Metabolic Reprogramming in Mitochondria of Myeloid Cells
por: Zuo, Hao, et al.
Publicado: (2019)

Metabolic Reprogramming in Tumor Endothelial Cells
por: García-Caballero, Melissa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_66qfffhudb4qq0s46ip03c32ma